C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the Intima of Early Atherosclerotic Lesions of Human Coronary Arteries
- 1 September 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 18 (9) , 1386-1392
- https://doi.org/10.1161/01.atv.18.9.1386
Abstract
—There is increasing evidence that complement activation may play a role in atherogenesis. Complement proteins have been demonstrated to be present in early atherosclerotic lesions of animals and humans, and cholesterol-induced atherosclerotic lesion formation is reduced in complement-deficient animals. Potential complement activators in atherosclerotic lesions are now a subject matter of debate. C-reactive protein (CRP) is an acute-phase protein that is involved in inflammatory processes in numerous ways. It binds to lipoproteins and activates the complement system via the classic pathway. In this study we have investigated early atherosclerotic lesions of human coronary arteries by means of immunohistochemical staining. We demonstrate here that CRP deposits in the arterial wall in early atherosclerotic lesions with 2 predominant manifestations. First, there is a diffuse rather than a focal deposition in the deep fibroelastic layer and in the fibromuscular layer of the intima adjacent to the media. In this location, CRP frequently colocalizes with the terminal complement complex. Second, the majority of foam cells below the endothelium show positive staining for CRP. In this location, no colocalization with the terminal complement proteins can be observed. Our data suggest that CRP may promote atherosclerotic lesion formation by activating the complement system and being involved in foam cell formation.Keywords
This publication has 19 references indexed in Scilit:
- Immunohistochemical localization of C‐reactive protein‐binding sites in human atherosclerotic aortic lesions by a modified streptavidin‐biotin‐staining methodPathology International, 1995
- CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesionsAtherosclerosis, 1992
- Functions and relevance of the terminal complement sequenceAnnals of Hematology, 1990
- Elevation of C-reactive protein in “active” coronary artery diseaseThe American Journal of Cardiology, 1990
- Immunoglobulins and complement components in human aortic atherosclerotic intimaAtherosclerosis, 1985
- Immunohistochemical studies of c‐reactive protein and apolipoprotein b in inflammatory and arterial lesionsThe Journal of Pathology, 1985
- ACCUMULATION OF IgG AND COMPLEMENT FACTOR C3 IN HUMAN ARTERIAL ENDOTHELIUM AND ATHEROSCLEROTIC LESIONSActa Pathologica Microbiologica Scandinavica Series A :Pathology, 1984
- Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein.The Journal of Experimental Medicine, 1982
- PHYLOGENETIC ASPECTS OF C‐REACTIVE PROTEIN AND RELATED PROTEINS*Annals of the New York Academy of Sciences, 1982
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981